Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- adjective Not
squamous .
Etymologies
from Wiktionary, Creative Commons Attribution/Share-Alike License
Support
Help support Wordnik (and make this page ad-free) by adopting the word nonsquamous.
Examples
-
The companies have been developing the drug, motesanib, to be taken with the existing treatments paclitaxel and carboplatin to fight advanced nonsquamous, non-small-cell lung cancer.
Amgen Cancer Drug Fails in Late-Stage Study Matt Jarzemsky 2011
-
Inc., the oral drug did reach its secondary goal of so-called progression-free survival where the disease didn't get worse in patients with nonsquamous, nonsmall-cell lung cancer, Bayer said.
Corporate Watch 2010
-
Inc., the oral drug did reach its secondary goal of so-called progression-free survival where the disease didn't get worse in patients with nonsquamous, nonsmall-cell lung cancer, Bayer said.
-
Amgen and Takeda expect to release results this year from a trial testing motesanib in combination with chemotherapy for patients with nonsquamous, non-small cell lung cancer, Harper said.
-
Amgen and Takeda expect to release results this year from a trial testing motesanib in combination with chemotherapy for patients with nonsquamous, non-small cell lung cancer, Harper said.
-
A total of 939 patients with advanced nonsquamous NSCLC were enrolled in the study; 539 did not progress during the induction phase and entered the maintenance phase of the trial.
unknown title 2011
-
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion for the use of Alimta® as continuation maintenance therapy in patients with advanced nonsquamous non-small cell lung cancer (NSCLC).
unknown title 2011
-
PARAMOUNT: Phase III study of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC).
unknown title 2011
-
The study included patients with advanced nonsquamous NSCLC who received ALIMTA (500 mg/m2 on day one of a 21-day cycle) in combination with cisplatin (75 mg/m2) induction therapy.
unknown title 2011
-
Data published today in The Lancet showed a survival benefit in nonsquamous patients with advanced n ...
THE MEDICAL NEWS Editors 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.